Zdrowie i gospodarka · 30/01/2018

FDA Announces Draft Guidance on Qualified Infectious Disease Product Designation Questions and Answers

The FDA is releasing a draft guidance to provide information on its policies and procedures for designating qualified infectious disease products, which are incentivized under the Food and Drug Administration Safety and Innovation Act for the development of antibacterial and antifungal treatments for serious infections.